Research programme: anti-infective therapeutics - ImCheck Therapeutics
Latest Information Update: 07 Dec 2020
At a glance
- Originator ImCheck Therapeutics
- Class Anti-infectives; Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Research Infections